These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3137281)

  • 1. [Protective effect of glycolipid containing mycolic acid derived from Gordona aurantiaca against Yersinia enterocolitica].
    Fujita T; Kawata Y; Kitamura F; Sugimoto N; Yano I; Sawai H; Kato Y; Miyama A
    Kansenshogaku Zasshi; 1988 Jan; 62(1):26-31. PubMed ID: 3137281
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective effects of glycolipids (Rt. GM-2) containing mycolic acid from Rhodococcus terrae on influenza virus infection in mice].
    Sugimoto N; Sumi Y; Fujita T; Kawata Y; Kato K; Yano I; Hattori N; Kurimura T
    Kansenshogaku Zasshi; 1987 Nov; 61(11):1248-51. PubMed ID: 2835414
    [No Abstract]   [Full Text] [Related]  

  • 3. Granuloma-forming activity and antitumor activity of newly isolated mycoloyl glycolipid from Rhodococcus terrae 70012 (Rt. GM-2).
    Natsuhara Y; Yoshinaga J; Shogaki T; Sumi-Nishikawa Y; Kurano S; Kato Y; Kaneda K; Oka S; Yano I
    Microbiol Immunol; 1990; 34(1):45-53. PubMed ID: 2325578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aporphinoid alkaloids as antimicrobial agents against Yersinia enterocolitica.
    Di Marco N; Lucero-Estrada C; R Pungitore C
    Lett Appl Microbiol; 2019 May; 68(5):437-445. PubMed ID: 30687933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice against parenteral and oral infection with Yersinia enterocolitica.
    Nakajima R; Kaneko K; Hashimoto N
    Nihon Juigaku Zasshi; 1984 Oct; 46(5):721-7. PubMed ID: 6513245
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycolyl glycolipids stimulate macrophages to release a chemotactic factor.
    Matsunaga I; Oka S; Inoue T; Yano I
    FEMS Microbiol Lett; 1990 Jan; 55(1-2):49-53. PubMed ID: 2328910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of protective immunity induced by Yersinia enterocolitica type-III secretion system mutants.
    Mamroud E; Flashner Y; Tidhar A; Ber R; Gur D; Aftalion M; Lazar S; Velan B; Shafferman A; Cohen S
    Adv Exp Med Biol; 2003; 529():425-30. PubMed ID: 12756803
    [No Abstract]   [Full Text] [Related]  

  • 8. [An immune adjuvant activity of mycolic acid-containing glycolipid, trehalose-2,3,6'-trimycolate, derived from Gordona aurantiaca].
    Ohtsubo Y; Furukawa M; Fujinobu Y; Sugimoto N; Ikutoh M; Katoh Y; Yano I; Higasa M; Shinka S; Dohi Y
    Nihon Saikingaku Zasshi; 1989 Mar; 44(2):533-9. PubMed ID: 2788754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG protection of mice challenged with virulent Yersinia enterocolitica.
    Santos Filho L; Ricciard ID; Pinto Gontijo Filho P
    Rev Latinoam Microbiol; 1982; 24(1):11-3. PubMed ID: 7186672
    [No Abstract]   [Full Text] [Related]  

  • 10. A new quantitative method for oral vaccination of killed cells and persistence of the vaccination against fecal excretion of Yersinia enterocolitica.
    Yanagisawa J; Kaneko K; Hayashidani H; Ogawa M
    Nihon Juigaku Zasshi; 1987 Oct; 49(5):795-9. PubMed ID: 3682519
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of transfusion of Yersinia enterocolitica.
    Jones BL; Hanson MF
    J Hosp Infect; 1994 Nov; 28(3):236-8. PubMed ID: 7852738
    [No Abstract]   [Full Text] [Related]  

  • 12. In-vitro and in-vivo activities of antibiotics on Yersinia enterocolitica.
    Scavizzi MR; Gayraud M; Hornstein MJ; Jupeau-Vessieres AM; Bronner FD; Elbhar A
    J Antimicrob Chemother; 1996 Dec; 38(6):1108-9. PubMed ID: 9023662
    [No Abstract]   [Full Text] [Related]  

  • 13. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
    Singh AK; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between structure and biological activity of the mycolic acid-containing glycolipids from Nocardia asteroides "sensu stricto" and related species.
    Han Y; He H; Oka S; Yano I
    Acta Leprol; 1989; 7 Suppl 1():130-2. PubMed ID: 2503969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the efficacy of Enterocoliticin, a phage-tail like bacteriocin, as antimicrobial agent against Yersinia enterocolitica serotype O3 in a cell culture system and in mice.
    Damasko C; Konietzny A; Kaspar H; Appel B; Dersch P; Strauch E
    J Vet Med B Infect Dis Vet Public Health; 2005 May; 52(4):171-9. PubMed ID: 16000112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against the lethal effect and arthritogenic capacity of Yersinia enterocolitica serovar O:3 for mice.
    de los Toyos JR; Díaz R; Hardisson C
    FEMS Microbiol Immunol; 1991 Oct; 3(5):289-97. PubMed ID: 1797050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the combination of clavulanic acid and cephalothin on an experimental infection with Yersinia enterocolitica in iron-overloaded mice.
    Jimenez-Valera M; Ruiz-Bravo A; Gómez MC; Ramos-Cormenzana A
    J Antimicrob Chemother; 1988 Nov; 22(5):707-13. PubMed ID: 3209528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of polyvalent Yersinia enterocolitica bacteriophage preparation for medical prophylactic use.
    Darsavelidze M; Kapanadze Z; Chanishvili T; Suladze T; Elizbarashvil M; Dvalishvili M
    Adv Exp Med Biol; 2003; 529():473-6. PubMed ID: 12756813
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity of 24 antimicrobials against Yersinia enterocolitica.
    Stolk-Engelaar V; Meis J; Mulder J; Loeffen F; Hoogkamp-Korstanje J
    Contrib Microbiol Immunol; 1995; 13():172-4. PubMed ID: 8833826
    [No Abstract]   [Full Text] [Related]  

  • 20. Desferrioxamine-promoted virulence of Yersinia enterocolitica in mice depends on both desferrioxamine type and mouse strain.
    Autenrieth IB; Reissbrodt R; Saken E; Berner R; Vogel U; Rabsch W; Heesemann J
    J Infect Dis; 1994 Mar; 169(3):562-7. PubMed ID: 8158027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.